Interleukin-4-Loaded lipid nanoparticles reprogram adipose tissue immunity and promote adipocyte browning for the treatment of obesity
Acta Biomaterialia · 2026-11 · 225 · 632-644
DOI: 10.1016/j.actbio.2026.09.007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Biomaterialia, 2026-11. Verfasst von Neda Mohaghegh und 10 weiteren Autor:innen. Beteiligte Einrichtung: Terasaki Institute for Biomedical Innovation, Woodland Hills, CA, 91367 USA. Hauptthemen laut MEDLINE: Interleukin-4, Obesity, Nanoparticles, Lipids. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Cincinnati, Terasaki Institute for Biomedical Innovation.
Abstract (Originalsprache)
Obesity represents a global health crisis characterized by chronic adipose tissue (AT) inflammation (metaflammation) driven by pro-inflammatory M1 macrophage (MΦ) polarization, adipocyte hypertrophy, and impaired thermogenic capacity of white adipose tissue (WAT). While interleukin-4 (IL-4) potently induces M2 MΦ polarization, its clinical translation is limited by poor stability, rapid clearance, and off-target effects. Here, we engineered lipid nanoparticles (IL-4/LNP) via simple, robust thin-film hydration and extrusion to enable sustained IL-4 delivery to MΦs in inflamed AT. In vitro, IL-4/LNP achieved >70% encapsulation efficiency, a uniform ∼150 nm size, and superior M1 to M2 MΦ reprogramming compared with free IL-4, as evidenced by CD206 upregulation, reduced CD80/CD40 expression, and attenuated TNF-α/IL-6 secretion in LPS-stimulated MΦ. In adipocyte-mimicking cells (3T3-L1)-MΦ co-cultures representing white and brown adipose tissue (BAT), paracrine signaling from IL-4/LNP-polarized M2 MΦs drove a profound reduction in lipid droplets (LDs) and beiging, with decreased Feret diameter and integrated optical density. Using a high-fat diet-induced obese mouse model, localized inguinal/visceral AT injections blunted weight gain by ∼10%, induced multilocular beige-like adipocytes across depots, upregulated thermogenic genes (UCP1 and PGC1α), downregulated inflammatory markers (IL-6), and improved hepatic steatosis without systemic toxicity. These findings establish IL-4/LNP as a safe, multifunctional platform that links MΦ immunomodulation and adipose browning in obesity therapy. STATEMENT OF SIGNIFICANCE: This study establishes IL-4-loaded lipid nanoparticles (IL-4/LNPs) as a nanomedicine platform that targets the immunometabolic roots of obesity by reprogramming adipose tissue macrophages and promoting white fat browning. IL-4/LNPs are produced by a simple, scalable thin-film hydration-extrusion method, yielding ∼150 nm particles with ∼73% encapsulation, suitable for local adipose delivery. In vitro, the NPs outperform free IL-4 by enhancing M2 polarization, driving paracrine adipocyte remodeling, and reducing lipid burden in 3T3-L1 co-cultures. In high-fat diet-obese mice, depot-specific IL-4/LNP injections limit weight gain, induce adipocyte beiging, improve hepatic steatosis, and reduce systemic inflammation without detectable toxicity, supporting IL-4/LNPs as a translatable cytokine nanotherapy for metaflammatory obesity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Terasaki Institute for Biomedical Innovation, Woodland Hills, CA, 91367 USA.
- Terasaki Institute for Biomedical Innovation, Woodland Hills, CA, 91367 USA; Department of Ophthalmology and Visual Sciences, University of Illinois Chicago, 835 S. Wolcott Avenue, Chicago, IL, 60612, USA.
- Department of Pharmaceutical Sciences, University of Cincinnati, James L. Winkle College of Pharmacy, Cincinnati, OH, 45267, USA.
- Materials Science and Engineering, Korea University, Seoul, 02841, South Korea.
- Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, MD, 21201, USA.
- Terasaki Institute for Biomedical Innovation, Woodland Hills, CA, 91367 USA; Department of Pharmaceutical Sciences, University of Cincinnati, James L. Winkle College of Pharmacy, Cincinnati, OH, 45267, USA. Electronic a…
Förderung
- University of Cincinnati
- Terasaki Institute for Biomedical Innovation
Zitieren
APA
Mohaghegh, N., Zargar Balajam, N., Kraemer, N., Marx, T., Sawant, S., Digholkar, G. Y., O'Raw, A., Shen, X., Kang, H., Pearson, R. M., & Hassani Najafabadi, A. (2026). Interleukin-4-Loaded lipid nanoparticles reprogram adipose tissue immunity and promote adipocyte browning for the treatment of obesity. Acta Biomaterialia, 225, 632-644. https://doi.org/10.1016/j.actbio.2026.09.007
Vancouver
Mohaghegh N, Zargar Balajam N, Kraemer N, Marx T, Sawant S, Digholkar GY, et al. Interleukin-4-Loaded lipid nanoparticles reprogram adipose tissue immunity and promote adipocyte browning for the treatment of obesity. Acta Biomaterialia. 2026;225:632-644. doi:10.1016/j.actbio.2026.09.007
BibTeX
@article{Mohaghegh2026,
author = {Mohaghegh, Neda and Zargar Balajam, Narges and Kraemer, Nick and Marx, Talia and Sawant, Shraddha and Digholkar, Gargi Y and O'Raw, Aliesha and Shen, Xiling and Kang, Heemin and Pearson, Ryan M and Hassani Najafabadi, Alireza},
title = {Interleukin-4-Loaded lipid nanoparticles reprogram adipose tissue immunity and promote adipocyte browning for the treatment of obesity},
journal = {Acta Biomaterialia},
year = {2026},
volume = {225},
pages = {632--644},
doi = {10.1016/j.actbio.2026.09.007}
}
EUVIMED